IPO Boutique

Vitae Pharmaceuticals, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Vitae Pharmaceuticals, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Vitae Pharmaceuticals, Inc.VTAE -
NASDAQ
$11.00-$13.00 $8.00 $8.006.875 million9/24/2014
Stifel, BMO Capital Markets
Co-Manager(s):
JMP Securities, Wedbush PacGrow Life Sciences
Health Care
Filing(s):

Filed 2014-08-12
Terms Added 2014-09-08



Vitae Pharmaceuticals, Inc. Quote & Chart - Click for current quote - VTAE

About Vitae Pharmaceuticals, Inc. (adapted from Vitae Pharmaceuticals, Inc. prospectus):
They are a clinical stage biotechnology company focused on discovering and developing novel, small molecule drugs for diseases that represent large market opportunities where there are significant unmet medical needs.

This description is adapted from Vitae VTAE prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as Vitae VTAE "VTAE" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved